Tardif, M

Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Dec 1998 - 6885-95 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0022-1767


Androstadienes--pharmacology
Bucladesine--pharmacology
Calcium-Calmodulin-Dependent Protein Kinases--metabolism
Cell Differentiation--drug effects
Dimethyl Sulfoxide--pharmacology
Enzyme Activation--drug effects
Enzyme Inhibitors--pharmacology
Flavonoids--pharmacology
GTP-Binding Proteins--genetics
HL-60 Cells--drug effects
Humans
Isoenzymes--metabolism
MAP Kinase Kinase Kinase 1
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Models, Biological
N-Formylmethionine Leucyl-Phenylalanine--analogs & derivatives
NADPH Oxidases--metabolism
Neoplasm Proteins--metabolism
Oxidation-Reduction
Oxidative Stress
Phosphatidylinositol 3-Kinases--physiology
Phosphoinositide-3 Kinase Inhibitors
Phosphoproteins--metabolism
Phosphorylation--drug effects
Protein Kinase C--metabolism
Protein Processing, Post-Translational--drug effects
Protein Serine-Threonine Kinases--antagonists & inhibitors
Recombinant Fusion Proteins--physiology
Signal Transduction--drug effects
Tetradecanoylphorbol Acetate--pharmacology
Transfection
Virulence Factors, Bordetella--pharmacology
Wortmannin
rac GTP-Binding Proteins